The effects of diuretics and adrenergic-blocking agents on plasma lipids

J J Rohlfing, J D Brunzell, J J Rohlfing, J D Brunzell

Abstract

ANTIHYPERTENSIVE MEDICATIONS CAUSE THE FOLLOWING CHANGES IN PLASMA LIPIDS AND LIPOPROTEINS: Thiazide and loop diuretics increase triglyceride, total cholesterol and low-density-lipoprotein (LDL) cholesterol levels with no change in high-density-lipoprotein (HDL) cholesterol. beta-Adrenergic antagonists increase triglyceride and decrease HDL cholesterol levels. A rise in very-low-density-lipoprotein (VLDL) cholesterol balances the decrease in HDL cholesterol, so that there is no significant change in total cholesterol. alpha-Adrenergic antagonists decrease triglyceride, increase HDL cholesterol and may decrease VLDL and LDL cholesterol. Labetalol, with both alpha- and beta-adrenergic antagonistic activity, does not affect plasma lipids in a small number of studies. The calcium channel blockers nifedipine and verapamil also have no consistent effect on lipoprotein levels in a small number of studies.

References

    1. Am J Med. 1984 Feb 27;76(2A):113-6
    1. Am J Med. 1984 Feb 27;76(2A):52-66
    1. Am J Med. 1984 Feb 27;76(2A):72-8
    1. Am J Med. 1984 Feb 27;76(2A):79-84
    1. Am J Med. 1984 Feb 27;76(2A):89-93
    1. Acta Med Scand Suppl. 1984;681:43-8
    1. Acta Med Scand Suppl. 1984;681:49-51
    1. Br Heart J. 1984 Jun;51(6):589-94
    1. Atherosclerosis. 1984 May-Jun;51(2-3):335-8
    1. Clin Pharmacol Ther. 1984 Aug;36(2):157-62
    1. Methods Find Exp Clin Pharmacol. 1984 Aug;6(8):471-4
    1. Am J Med. 1984 Nov;77(5):823-7
    1. Atherosclerosis. 1981 Jun;39(3):301-6
    1. S Afr Med J. 1981 Sep 5;60(10):379-80
    1. Eur J Clin Pharmacol. 1981;20(5):335-8
    1. N Engl J Med. 1981 Dec 10;305(24):1455-7
    1. J Lipid Res. 1981 Nov;22(8):1265-70
    1. Med Clin North Am. 1982 Mar;66(2):455-68
    1. Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1145-8
    1. Ann Intern Med. 1982 Aug;97(2):206-9
    1. Atherosclerosis. 1971 Sep-Oct;14(2):283-7
    1. Clin Chem. 1972 Jun;18(6):499-502
    1. J Clin Invest. 1973 Jul;52(7):1578-85
    1. Lancet. 1975 Jan 4;1(7897):16-9
    1. Lancet. 1976 Apr 3;1(7962):721-3
    1. Drugs. 1976;11 SUPPL 1:121-6
    1. Metabolism. 1976 Oct;25(10):1071-5
    1. Br Med J. 1977 Jul 9;2(6079):126
    1. Metabolism. 1977 Aug;26(8):903-10
    1. Br Med J. 1978 Apr 15;1(6118):986
    1. Br Med J. 1978 Aug 5;2(6134):403
    1. JAMA. 1978 Dec 1;240(23):2553-6
    1. Br Med J. 1978 Nov 25;2(6150):1495
    1. Clin Sci Mol Med Suppl. 1978 Dec;4:323s-324s
    1. Clin Sci Mol Med Suppl. 1978 Dec;4:325s-328s
    1. Br Med J. 1979 Jan 13;1(6156):77-80
    1. Br Med J. 1979 Jan 20;1(6157):159-61
    1. Biochem J. 1978 Dec 15;176(3):865-72
    1. J Lipid Res. 1979 Feb;20(2):200-7
    1. Curr Med Res Opin. 1979;6(1):24-9
    1. Pharmacol Res Commun. 1979 Mar;11(3):227-36
    1. Int J Clin Pharmacol Biopharm. 1979 Sep;17(9):378-82
    1. Postgrad Med J. 1979 Oct;55(648):709-11
    1. Clin Sci (Lond). 1979 Dec;57 Suppl 5:405s-407s
    1. Metabolism. 1980 Mar;29(3):240-5
    1. Lancet. 1980 Jul 5;2(8184):4-6
    1. Atherosclerosis. 1980 May;36(1):111-5
    1. Klin Wochenschr. 1980 Apr 1;58(7):359-63
    1. Naunyn Schmiedebergs Arch Pharmacol. 1980 Apr;311(3):237-48
    1. Clin Exp Pharmacol Physiol. 1980 May-Jun;7(3):329-33
    1. JAMA. 1980 Oct 10;244(15):1691-5
    1. Hypertension. 1980 Sep-Oct;2(5):672-9
    1. Am J Med. 1980 Nov;69(5):725-32
    1. Curr Med Res Opin. 1980;7(2):101-3
    1. Ann Intern Med. 1981 Jan;94(1):7-11
    1. Lancet. 1981 Jan 17;1(8212):163
    1. Br Med J (Clin Res Ed). 1981 May 30;282(6278):1741-4
    1. Klin Wochenschr. 1981 Apr 1;59(7):343-6
    1. Br J Clin Pharmacol. 1982;13(Suppl 2):435S-439S
    1. Br J Clin Pharmacol. 1982;13(Suppl 2):445S-447S
    1. Acta Cardiol. 1982;37(4):235-44
    1. Scand J Clin Lab Invest. 1982 Sep;42(5):449-53
    1. Clin Pharmacol Ther. 1983 Mar;33(3):294-300
    1. Aust N Z J Med. 1982 Dec;12(6):612-6
    1. Int J Clin Pharmacol Ther Toxicol. 1983 Apr;21(4):189-91
    1. Eur J Clin Pharmacol. 1983;24(5):573-7
    1. Am J Cardiol. 1984 Jan 27;53(3):40A-45A
    1. Am J Med. 1984 Feb 27;76(2A):101-4
    1. Am J Med. 1984 Feb 27;76(2A):105-8
    1. Am J Med. 1984 Feb 27;76(2A):109-12

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner